Clinical Trial Update: Indicated Prevention of Psychotic Disorders With Low-dose Lithium [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether low-dose lithium can prevent the onset of psychotic disorders in individuals with schizophrenia or bipolar disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: Melbourne Health | Conditions: Schizophrenia, Bipolar Disorder | Phase 4 | Status: COMPLETED